Clinical TrialsCelldex Ends Barzolvolimab Development in Prurigo Nodularis After Phase 2 T... Celldex Ends Barzolvolimab Development in Prurigo Nodularis After Phase 2 T... Read Post »
Clinical TrialsSummit Therapeutics Reports Updated Overall Survival Analysis from Phase II... Summit Therapeutics Reports Updated Overall Survival Analysis from Phase II... Read Post »
GenericsFDA Expands Glenmark’s RYALTRIS Use for Seasonal Allergic Rhinitis in... FDA Expands Glenmark’s RYALTRIS Use for Seasonal Allergic Rhinitis in... Read Post »
Health TidingsIslatravir/Lenacapavir Maintains Virological Suppression Through 48 Weeks i... Islatravir/Lenacapavir Maintains Virological Suppression Through 48 Weeks i... Read Post »
New Drug ApprovalMHRA Approves World’s First Lower-Carbon Beclometasone Inhalers for Asthm... MHRA Approves World’s First Lower-Carbon Beclometasone Inhalers for Asthm... Read Post »
Clinical TrialsActinogen’s Xanamem Shows Antidepressant Benefit in Phase 2 MDD Trial Actinogen’s Xanamem Shows Antidepressant Benefit in Phase 2 MDD Trial Read Post »
Clinical TrialsGilead to Present Long-Term Lenacapavir, ISLEND and HIV Pipeline Data at AI... Gilead to Present Long-Term Lenacapavir, ISLEND and HIV Pipeline Data at AI... Read Post »
Health TidingsTempest Advances TPST-4003 Toward First Clinical Evaluation of In Vivo CAR-... Tempest Advances TPST-4003 Toward First Clinical Evaluation of In Vivo CAR-... Read Post »
Regulatory & Health PolicyAlpha Tau Reports 100% Response Rate with Alpha DaRT Plus Keytruda in Early... Alpha Tau Reports 100% Response Rate with Alpha DaRT Plus Keytruda in Early... Read Post »
Health TidingsIMUNON Reports Positive Phase 2 Translational Data Supporting IMNN-001 in A... IMUNON Reports Positive Phase 2 Translational Data Supporting IMNN-001 in A... Read Post »
Medical DevicesEnvoy Medical Completes Three-Month Milestone in Acclaim Cochlear Implant T... Envoy Medical Completes Three-Month Milestone in Acclaim Cochlear Implant T... Read Post »
Health TidingsNOUS-209 Re-Treatment Boosts Durable T-Cell Responses in Lynch Syndrome NOUS-209 Re-Treatment Boosts Durable T-Cell Responses in Lynch Syndrome Read Post »
Health TidingsPhanes Advances Spevatamig-KYTRUDA in First-Line Biliary Tract Cancer with ... Phanes Advances Spevatamig-KYTRUDA in First-Line Biliary Tract Cancer with ... Read Post »
Clinical TrialsAkagera Reports Positive Data for Long-Acting AKG-100 in Drug-Resistant Tub... Akagera Reports Positive Data for Long-Acting AKG-100 in Drug-Resistant Tub... Read Post »
Clinical TrialsSamsung Bioepis and Harrow Present Positive Real-World Data for BYOOVIZ® B... Samsung Bioepis and Harrow Present Positive Real-World Data for BYOOVIZ® B... Read Post »
Clinical TrialsAgios Shifts PK Activation Strategy to Mitapivat After Tebapivat Falls Shor... Agios Shifts PK Activation Strategy to Mitapivat After Tebapivat Falls Shor... Read Post »
Health TidingsFDA Grants Fast Track Designation to Oncolytics’s Pelareorep FDA Grants Fast Track Designation to Oncolytics’s Pelareorep Read Post »
Clinical TrialsSura-vec Maintains Long-Term Vision Benefits in Wet AMD and Diabetic Retino... Sura-vec Maintains Long-Term Vision Benefits in Wet AMD and Diabetic Retino... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Halozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Read Post »
Clinical TrialsBiohaven Unveils Early Phase 1 BHV-1530 Data and Regeneron Partnership Biohaven Unveils Early Phase 1 BHV-1530 Data and Regeneron Partnership Read Post »
Clinical TrialsGreenwich Expands Phase III FLAMINGO 01 Trial After DSMB Support for GLSI 1... Greenwich Expands Phase III FLAMINGO 01 Trial After DSMB Support for GLSI 1... Read Post »
Health TidingsFDA Grants Priority Review to Dyne’s z-Rostudirsen for DMD FDA Grants Priority Review to Dyne’s z-Rostudirsen for DMD Read Post »
Health TidingsNamodenoson Shows Durable Disease Control in Advanced Pancreatic Cancer Namodenoson Shows Durable Disease Control in Advanced Pancreatic Cancer Read Post »
Health TidingsDuvakitug Improves Clinical Remission in Ulcerative Colitis Trial Duvakitug Improves Clinical Remission in Ulcerative Colitis Trial Read Post »
Health TidingsSafusidenib Delivers Long-Term Benefit in Grade 2 IDH1-Mutant Glioma Safusidenib Delivers Long-Term Benefit in Grade 2 IDH1-Mutant Glioma Read Post »
Health TidingsDuvakitug Shows Positive Phase 2b Results in Crohn’s Disease Duvakitug Shows Positive Phase 2b Results in Crohn’s Disease Read Post »
Clinical TrialsTinlarebant Demonstrates Consistent Phase 3 Benefit in Stargardt Disease Tinlarebant Demonstrates Consistent Phase 3 Benefit in Stargardt Disease Read Post »
New Drug ApprovalIndia’s First Approved Dengue Vaccine: CDSCO Clears Takeda’s QD... India’s First Approved Dengue Vaccine: CDSCO Clears Takeda’s QD... Read Post »
Clinical TrialsKolon TissueGene’s TG-C Misses Phase 3 Goals in Knee Osteoarthritis T... Kolon TissueGene’s TG-C Misses Phase 3 Goals in Knee Osteoarthritis T... Read Post »
Health TidingsEMA Accepts GSK’s Bexsero Single-Dose Booster Label Expansion EMA Accepts GSK’s Bexsero Single-Dose Booster Label Expansion Read Post »
Health TidingsPivotal Bexicaserin Trial Completes Randomization in Rare Childhood Epileps... Pivotal Bexicaserin Trial Completes Randomization in Rare Childhood Epileps... Read Post »
ResearchSelective RARβ Agonist KCL-286 Shows Promise in Alzheimer’s Study Selective RARβ Agonist KCL-286 Shows Promise in Alzheimer’s Study Read Post »
Clinical TrialsNG101 Gene Therapy Reduced Anti-VEGF Injection Frequency by 90% in Mid-Dose... NG101 Gene Therapy Reduced Anti-VEGF Injection Frequency by 90% in Mid-Dose... Read Post »
Clinical TrialsRaniPill RT-114 Shows Strong Bioavailability in Phase 1 Obesity Study RaniPill RT-114 Shows Strong Bioavailability in Phase 1 Obesity Study Read Post »
GenericsNATCO Pharma Secures Tentative US FDA Approval for Generic Olaparib Tablets NATCO Pharma Secures Tentative US FDA Approval for Generic Olaparib Tablets Read Post »
Clinical Trials4D-150 Maintains Vision and Cuts Injection Burden by Up to 87% Over Two Yea... 4D-150 Maintains Vision and Cuts Injection Burden by Up to 87% Over Two Yea... Read Post »
Health TidingsKamuvudine-8 Reduced Geographic Atrophy Progression by 54% in Phase 2 Study Kamuvudine-8 Reduced Geographic Atrophy Progression by 54% in Phase 2 Study Read Post »
Health TidingsInnoCare’s Soficitinib Meets Phase II Endpoint in Vitiligo InnoCare’s Soficitinib Meets Phase II Endpoint in Vitiligo Read Post »
GenericsAmneal Secures FDA Approval for Additional Iohexol Injection Presentations,... Amneal Secures FDA Approval for Additional Iohexol Injection Presentations,... Read Post »
Clinical TrialsInnoCare’s Soficitinib Meets Phase III Endpoint in Atopic Dermatitis InnoCare’s Soficitinib Meets Phase III Endpoint in Atopic Dermatitis Read Post »
Clinical TrialsMMV367 Rapidly Eliminates Blood-Stage Malaria Parasites in Early Study MMV367 Rapidly Eliminates Blood-Stage Malaria Parasites in Early Study Read Post »
Clinical TrialsIBC-Ab002 Shows Early Promise in Phase 1b Alzheimer’s Trial IBC-Ab002 Shows Early Promise in Phase 1b Alzheimer’s Trial Read Post »
Clinical Trials Mergers & AcquisitionsBayer Partners with Henry Ford Health to Expand Clinical Trials Bayer Partners with Henry Ford Health to Expand Clinical Trials Read Post »
New Drug ApprovalSystImmune Wins First Global Approval for Iza-bren, the First EGFR×HER3 Bi... SystImmune Wins First Global Approval for Iza-bren, the First EGFR×HER3 Bi... Read Post »
Health TidingsCamurus CAM2029 NDA Accepted by FDA for Acromegaly Camurus CAM2029 NDA Accepted by FDA for Acromegaly Read Post »
Clinical TrialsTakeda’s Zasocitinib Shows Phase 3 Efficacy in Scalp, Nail, Palmoplantar ... Takeda’s Zasocitinib Shows Phase 3 Efficacy in Scalp, Nail, Palmoplantar ... Read Post »
Clinical TrialsVeradermics Reports Positive Age-Based Phase 2/3 Data for VDPHL01 in Male H... Veradermics Reports Positive Age-Based Phase 2/3 Data for VDPHL01 in Male H... Read Post »
Clinical TrialsEvaxion Reports Three-Year EVX-01 Phase 2 Melanoma Results at ESMO 2026 Evaxion Reports Three-Year EVX-01 Phase 2 Melanoma Results at ESMO 2026 Read Post »
Health TidingsShionogi’s Fetroja sNDA Accepted by FDA for Pediatric Hospital Pneumonia ... Shionogi’s Fetroja sNDA Accepted by FDA for Pediatric Hospital Pneumonia ... Read Post »
Health TidingsFabhalta Secures Full FDA Approval to Slow Kidney Function Decline in IgA N... Fabhalta Secures Full FDA Approval to Slow Kidney Function Decline in IgA N... Read Post »
